Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The influence of medications on neurocognition in bipolar disorder.

× No keyword cloud information.

7 in total

1. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors: Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal: World Psychiatry Date: 2022-10 Impact factor: 79.683

2. Functional remediation for bipolar disorder.

Authors: Anabel Martínez-Arán; Carla Torrent; Brisa Solé; C Mar Bonnín; Adriane R Rosa; José Sánchez-Moreno; Eduard Vieta
Journal: Clin Pract Epidemiol Ment Health Date: 2011-06-06

3. Augmentative asenapine in a recurrent manic catatonic patient with partial response to clozapine.

Authors: Massimiliano Buoli; Cristina Dobrea; Alice Caldiroli; Laura Cremaschi; A Carlo Altamura
Journal: Case Rep Psychiatry Date: 2013-09-19

4. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.

Authors: Lejla Sjanic Schmidt; Jeff Zarp Petersen; Maj Vinberg; Ida Hageman; Niels Vidiendal Olsen; Lars Vedel Kessing; Martin Balslev Jørgensen; Kamilla Woznica Miskowiak
Journal: Trials Date: 2018-04-19 Impact factor: 2.279

5. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.

Authors: Jeff Zarp Petersen; Lejla Sjanic Schmidt; Maj Vinberg; Martin Balslev Jørgensen; Ida Hageman; Hannelore Ehrenreich; Gitte Moos Knudsen; Lars Vedel Kessing; Kamilla Woznica Miskowiak
Journal: Trials Date: 2018-11-06 Impact factor: 2.279

6. Effect of Pharmacological and Neurostimulation Interventions for Cognitive Domains in Patients with Bipolar Disorder: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Authors: Wen-Yin Chen; Hsing-Cheng Liu; Ying-Chih Cheng; Hua Li; Chi-Chieh Huang; Yu-Wei Ding; Ming-Chyi Huang; Chih-Chiang Chiu; Yu-Kang Tu; Po-Hsiu Kuo
Journal: Clin Epidemiol Date: 2021-10-29 Impact factor: 4.790

7. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force.

Authors: K W Miskowiak; K E Burdick; A Martinez-Aran; C M Bonnin; C R Bowie; A F Carvalho; P Gallagher; B Lafer; C López-Jaramillo; T Sumiyoshi; R S McIntyre; A Schaffer; R J Porter; I J Torres; L N Yatham; A H Young; L V Kessing; E Vieta
Journal: Bipolar Disord Date: 2017-09-12 Impact factor: 6.744

7 in total